PT  - JOURNAL ARTICLE
AU  - Catherine Jane McAllister
AU  - Claire Louise Kelly
AU  - Katherine Elizabeth Manning
AU  - Anthony John Holland
TI  - Participant experience of invasive research in adults with intellectual disability
AID  - 10.1136/medethics-2012-101077
DP  - 2013 Sep 01
TA  - Journal of Medical Ethics
PG  - 594--597
VI  - 39
IP  - 9
4099  - http://jme.bmj.com/content/39/9/594.short
4100  - http://jme.bmj.com/content/39/9/594.full
SO  - J Med Ethics2013 Sep 01; 39
AB  - Clinical research is a necessity if effective and safe treatments are to be developed. However, this may well include the need for research that is best described as ‘invasive’ in that it may be associated with some discomfort or inconvenience. Limitations in the undertaking of invasive research involving people with intellectual disabilities (ID) are perhaps related to anxieties within the academic community and among ethics committees; however, the consequence of this neglect is that innovative treatments specific to people with ID may not be developed. Such concerns are likely to continue while there is limited published knowledge regarding the actual experiences of people with ID who have participated in invasive clinical research. As part of a pilot study trialling the novel use of a surgically inserted device to curb overeating in people with Prader–Willi syndrome (PWS) we have investigated the experience of research through semistructured qualitative interviews involving three participants and their carers. Thematic analysis revealed that the adults with PWS and their family carers rated their participation positively, seeing it as a rewarding and enriching experience. This brief report discusses findings from our interview data in order to highlight strategies which may ensure that research is acceptable to participants, meets the necessary ethical standards and is able to achieve the aims set out by the researchers. To our knowledge, this is the first study to record experiences directly from people with PWS and their carers regarding their involvement in invasive clinical research.